Quality assessment | No. of patients | Effect | Quality | Importance | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of studies | Design | Limitations | Inconsistency | Indirectness | Imprecision | Other considerations | Risedronate groups | Control groups | Relative (95% CI) | Absolute | ||
BMD in Gruen zone 1 at 6 months (follow-up 6 months; better indicated by lower values) | ||||||||||||
4 | Randomized trials | No serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | None | 97 | 101 | – | SMD = 0.758, 95% CI 0.469 to 1.047 | High | Critical |
BMD in Gruen zone 2 at 6 months (follow-up 6 months; better indicated by lower values) | ||||||||||||
4 | Randomized trials | No serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | None | 97 | 101 | – | SMD = 0.814, 95% CI 0.523 to 1.106 | High | Critical |
BMD in Gruen zone 3 at 6 months (follow-up 6 months; better indicated by lower values) | ||||||||||||
4 | Randomized trials | No serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | None | 97 | 101 | – | SMD = 0.340, 95% CI 0.059 to 0.622 | High | Critical |
BMD in Gruen zone 4 at 6 months (follow-up 6 months; better indicated by lower values) | ||||||||||||
4 | Randomized trials | No serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | None | 97 | 101 | – | SMD = 0.275, 95% CI − 0.007 to 0.556 | High | Critical |
BMD in Gruen zone 5 at 6 months (follow-up 6 months; better indicated by lower values) | ||||||||||||
4 | Randomized trials | No serious limitations | Serious inconsistency | No serious indirectness | No serious imprecision | None | 97 | 101 | – | SMD = 0.204, 95% CI − 0.076 to 0.448 | High | Critical |
BMD in Gruen zone 6 at 6 months (follow-up 6 months; better indicated by lower values) | ||||||||||||
4 | Randomized trials | No serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | None | 97 | 101 | – | SMD = 0.503, 95% CI 0.218 to 0.788 | High | Critical |
BMD in Gruen zone 7 at 6 months (follow-up 6 months; better indicated by lower values) | ||||||||||||
4 | Randomized trials | No serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | None | 97 | 101 | – | SMD = 2.400, 95% CI 2.029 to 2.771 | High | Critical |